Prothena Corp Public (PRTA) Capital Expenditures (2012 - 2025)

Prothena Corp Public's Capital Expenditures history runs 14 years deep, the most recent figure standing at $10000.0 for Q3 2025.

• On a quarterly basis, Capital Expenditures rose 11.11% year-over-year to $10000.0 in Q3 2025; TTM through Mar 2026 was $96000.0, a 59.49% decrease from a year earlier, with the FY2025 full-year figure at $138000.0, down 53.69% from the prior year.
• Capital Expenditures eased to $10000.0 in Q3 2025 per PRTA's latest filing, from $86000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $1.5 million in Q4 2023 and bottomed at $9000.0 in Q3 2024.
• The 5-year median for Capital Expenditures is $116500.0 (2022), against an average of $238055.6.
• Across the five-year window, Capital Expenditures jumped 925.83% in 2023 and sank 97.96% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at $319000.0 in 2021, then tumbled by 52.66% to $151000.0 in 2022, then soared by 925.83% to $1.5 million in 2023, then plunged by 97.22% to $43000.0 in 2024, then plunged by 76.74% to $10000.0 in 2025.
• Per Business Quant, the three latest PRTA Capital Expenditures figures stand at $10000.0 (Q3 2025), $86000.0 (Q2 2025), and $42000.0 (Q1 2025).